MitoImmune Therapeutics Inc.

MIT Platform

SHARE

MIT platform is a MitoImmune’s proprietary technology that is centered 7-amino indole core structure. MIT compounds based the platform have a unique capability to permeate into negatively charge mitochondrial matrix. The MIT platform inhibits ferroptosis and blocks the DAMPs release and cytokine storm.

Most popular related searches